Get Fresh Tips Every Week!
Don't Miss Any ALS Tips. Subscribe to the ALS Tip Newsletter.

View Archive

Bookmark This Site
Keep up with our Tips


Tip of the Day RSS Feed
Fresh ALS Tips Daily


Business Solutions
Our tips are powerful.
Our writers are experts.
Our results are guaranteed.

 

Listen to our Radio Show
Hot topics for both consumers
and webmarketers
on WebmasterRadio.FM

Every Wednesday, 5PM Eastern.

 



Research On Rilutek ©

Rilutek © was designed by the pharmaceutical company Aventis Pharma. The FDA approved it in December 1995, with the generic name of Riluzole. During its clinical research trials, people with ALS took the drug for a thirteen to eighteen month period.

Rilutek © works on a neurotransmitter called glutamate. Neurotransmitters are chemical substances nerves use to transmit impulses from one nerve cell to the next. A popular theory believes the accumulation in the amount of glutamate causes the death of nerve cells. Rilutek © functions to block the amount of glutamate produced, and gives protection to the nerve cell. However, the whole process of how the drug acts to block glutamate or protect nerve cells is unknown.
5.9 5.9
Save Tip Tip Rating

Comments

Nobody has commented on this tip yet. Be the first.

Name:


URL: (optional)


Comment:




Learn more about our Content Development Solutions we offer our clients.